Hepatitis C New Drug Research And Liver Health
  • HCV News Of The Day
    • 2013/HCV Drugs News Digest
    • HCV Drugs: News Digest>
      • News Archive
      • Liver HCV : Specialty news digest
  • 2013 - Breaking Conference Reports/Hepatitis C
    • Breaking Conference Reports >
      • EASL 2012 Meeting Summary>
        • EASL Summary Of The 2011 March Meeting
      • AASLD- Nov 2011 Annual Meeting>
        • Conference Archive
  • Blog: New HCV Drug Updates
  • HCV FAQ
  • HCV: Newly Diagnosed?
    • Challenges-issues in managing hepatitis C
    • Ask Me A Question About Hepatitis C
  • What to do with a positive hepatitis C test
  • 2013-HCV Abstract Corner
    • HCV Abstract Corner>
      • Archive; Abstract Corner
  • 2013-Hepatitis C Full Text Articles
    • Hepatitis C Treatment Complete Studies 2012>
      • Potential new method to block the lifecycle of the Hepatitis C virus
      • Hepatitis C Treatment Complete Studies 2011
  • 2013/HCV Multimedia Videos Podcasts
    • Multimedia/Videos-Podcasts>
      • Watch How Hepatitis C Protease Inhibitors Work>
        • Multimedia; Archives Videos and Podcasts
  • 2013 Stem Cell News and Research
    • Liver-2012 Stem Cell Updates
    • Liver: 2011 Stem Cell Updates
    • What Are Stem Cells?>
      • Future applications of human stem cells
  • Recommended; Stem Cell Blogs
  • Understanding Hepatitis C
  • Natural History Of HCV
    • A 20-year cohort study on the natural history of untreated HCV infection
  • Hepatitis C Disease Progression
    • NIH scientists identify likely predictors of hepatitis C severity
    • HCV Epidemiology, Diagnosis and Disease Progression
    • Hepatitis C may increase deaths from both liver-related and other diseases>
      • Mortality in advanced HCV /long-term peginterferon
    • Host Factors on Management of HCV
  • Transmission
    • How Soon To Initiate HCV Therapy After Transmission
    • Does the Hepatitis C virus survive in dried blood ?
    • Viral Load Tied to Vertical Transmission of Hepatitis C
    • Hey Can I Get Hep C From......
    • HCV infections transmitted via a clinical setting
    • What Should I Do If I Get A Needlestick
  • How are the different types of hepatitis transmitted
    • New challenges in viral hepatitis
    • Hepatitis A virus infection in high-risk subjects
  • Your Liver Functions
  • Liver Function Tests
    • HCV-Persistently Normal (ALT) Alanine Aminotransferase Levels
    • Hey, I have a question about hcv tests and my liver
    • ALT used to separate those infected with HCV from those at low risk of liver disease
  • Lab Reports
  • HCV Viral Load Test
  • Liver Biopsy/Noninvasive Tests
    • Is there still a role for liver biopsy in managing hepatitis C virus infections?
    • Overview of Liver Biopsy Procedure
    • Three Algorithms of Non-invasive Markers of Fibrosis in Chronic Hepatitis C
    • FibroScan comparison to liver fibrosis biomarkers
  • Chronic HCV Symptoms
    • Fatigue and HCV
    • Sleep Disturbance in Chronic HCV
    • Skin Rash/Hepatitis C
    • Liver Disease: Bone Loss "It Ain't Like Menopause!"
  • HCV Neuropsychiatric symptoms-“brain fog”
    • HCV-Related Nervous System Disorders
    • Hepatitis C Virus and the Brain
    • Liver-induced inflammation hurts the brain
    • The Brain on Fire: Inflammation and Depression
  • Conditions Outside The Liver
    • Prevalence of fibromyalgia among patients with chronic hepatitis C
    • Lichen Planus and The Hepatitis C Virus
    • Dermatologic Disorders and Liver Disease
  • Chronic hepatitis C: Treat or wait?
    • Preparing For Treatment>
      • Starting Hepatitis C Treatment: Tips and Information 2011
      • Adherence To HCV Treatment-Review
      • Treating Hepatitis C; What can you do to increase your chance for SVR?
  • Hepatitis C advanced fibrosis: Treat or Wait
  • Approved Treatments for Hepatitis C
    • Adults:Treating Hepatitis C
    • Interferons and hepatitis C virus
  • HCV Treatment Failure Can Still Mean Less Liver Inflammation
  • Protease inhibitors geno-1:New standard of care
    • Treating HCV Genotype 1 In The Real World
    • 2012 - Direct acting antivirals for the treatment of chronic hepatitis C
    • HCV:End of the Beginning-Possibly-Beginning of the End
    • Patients’ Expectations About New HCV Direct-Acting Antivirals Often Unrealistic
    • What Are NS5A inhibitors ?
    • Hepatitis C Treatment Nonresponders
    • New 2011 AASLD guidelines for treating HCV
    • Treating New and Old Therapies>
      • High-grade liver inflammation may predict treatment response
  • HCV Resistance To New And Experimental Drugs
    • Understanding Resistance in Chronic HCV Infection
  • 2012 Future Prospects-Treatment of HCV
    • Advances in the treatment of hepatitis C virus infection.
  • Boceprevir & Telaprevir
    • FDA Telaprevir/Boceprevir Transcript
    • Pocket Guide Telaprevir/Boceprevir
    • Quick Facts- Direct-acting antivirals Telaprevir/Boceprevir
    • Telaprevir Or Boceprevir: What Is My Chance For A Cure?
  • 2013 News/Incivek (Telaprevir)
    • News/Telaprevir>
      • Telaprevir-IFN/ribavirin Hints at Response
      • Telaprevir FDA Approval>
        • Help-How Do I Take Incivek-telaprevir ?
        • Quick Study Of Telaprevir
        • Cost Of Treating With Telaprevir
  • 2013 News/Victrelis (Boceprevir)
    • News/ Boceprevir>
      • VICTRELIS-Boceprevir: Prescribing-Medication Guide
      • 2011;Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
      • 2011-Boceprevir for Untreated Chronic HCV Genotype 1 Infection
  • Side Effects-Interferon Free Therapies
  • Drug-Drug Interactions In Triple-Therapy
  • 2013/HCV Triple-therapy Side Effects
    • Boceprevir,Telaprevir Less Side Effects?>
      • 2013-HCV therapy geno 1: management of side-effects
      • Dry Mouth and Treatment >
        • Dry Mouth (Xerostomia)
      • Important updates to PegIntron labeling
      • Peginterferon alfa-2a Drug Interactions
      • HCV Treatment: Peginterferon and Ribavirin Side Effects
  • Genotypes/Treatment
    • Treatment Duration in Hepatitis C Virus Genotype 2/3-infected Patients
    • Impact of IL28B on Liver Histopathology in HCV Genotype 2/3
    • Genotype 3/HCV Treatment
    • HCV-Genotype 5 or 6
    • Hepatitis C-Genotype 4>
      • How to optimize HCV therapy in genotype 4 patients
      • Geno 4-Pioglitazone Decreases HCV Viral Load
    • Telaprevir/Boceprevir *genotype 1,2,3
    • (HCV) genotypes in the severity of liver disease
  • What Is The IL28B gene ?
    • Hepatitis C Test:Likelihood of achieving SVR>
      • IL28B and HCV immune responses
  • Index-Current Hepatitis C Drugs In Development
  • 2013-Interferon Free Combinations
    • Interferon-free combinations
    • 2013-Interferon free therapy w-direct acting antivirals for HCV
  • 2013 Sofosbuvir (GS-7977)
    • GS-7977-Formally PSI-7977 >
      • PSI-7977 peg/riba Geno 2/3 PROTON Trial
  • Sofosbuvir(GS7977)/Simeprevir(TMC435)
    • Interferon-Free Combo PSI-7977-TMC435
  • Sofosbuvir (GS-7977)/Ledipasvir (GS-5885)
  • GS-5885, an NS5A Inhibitor
  • ABT-450/r, ABT-267, ABT-333
  • Faldaprevir (BI 201335) and BI 207127 Interferon-Free
    • NS3/4A protease inhibitor BI201335
  • Miravirsen First MicroRNA-Targeted Drug
  • BMS-790052 (Daclatasvir)
  • Daclatasvir/VX135
  • ALS-2200 (VX-135)
  • BMS-790052/BMS-650032 Interferon-sparing
  • (TMC435) Simeprevir
  • TMC435 monotherapy in HCV genotypes 2-6
  • Simeprevir (TMC435) and TMC647055
  • Simeprevir,TMC647055 and IDX719
  • TMC435-daclatasvir-BMS-790052
  • Danoprevir-RG7227 direct-acting antiviral
  • Mericitabine- Polymerase Nuc
  • Sovaprevir (Formerly ACH-1625)
  • ACH-3102 NS5A inhibitor
  • INCIVEK, VX-222/Ribavirin
  • MK-5172 protease inhibitor
  • HCV/New Drug Pipeline
  • 2013/Hepatitis C Clinical Trials
    • Clinical Trials>
      • Learning About Clinical Trials
      • Boceprevir and Telaprevir Trials>
        • Telaprevir REALIZE STUDY
  • HCV Trials/Discontinued Or On Hold
    • Idenix IDX184-Hepatitis C drug
    • TMC435-BMS-986094-formerly INX-189
  • Women's Health; Treating Hepatitis C
    • Early Menopause and Response to HCV Treatment
  • Hepatitis C in Pregnancy
  • Treating Hepatitis C In Children
    • 2012 Hepatitis C infection in children
    • Autoimmunity/Extrahepatic Manifestations in HCV Treatment-Naïve Children
    • Study-long-term safety/durability of virologic response in paediatric patients who were previously treated w-interferon alfa-2b plus ribavirin for 48 weeks
  • Liver Disease in Elderly Patients
  • Dental considerations in patients with liver disease
    • HCV: Dental management-Diagnosis of extrahepatic manifestations>
      • Dental problems delaying the initiation of interferon
  • Fibrosis
    • Is there a natural way to improve liver fibrosis ?
  • 2013 News/Fibrosis
    • News: Fibrosis
  • Cirrhosis
    • What Is Cirrhosis ?
    • Advanced Liver Disease: What Every HCV Treater Should Know
    • The Patient With Cirrhosis: Don't Miss This
    • Hey, I have a question about cirrhosis
    • Physical Findings Suggestive Of Cirrhosis/Photos
    • Staging Cirrhosis>
      • When the Spleen Gets Tough, the Varices Get Going
    • Management Cirrhosis: How Are We Doing?
    • Cirrhosis Regression
    • Cirrhosis ; Surgery in the Patient with Liver Disease
    • Hepatic Encephalopathy>
      • Varices
      • Ascites
      • Management of ascites
  • 2013 News/Cirrhosis
    • News: Cirrhosis>
      • GI Bleeds: Withholding Transfusions Boosts Survival
  • Liver Transplant
    • New HCV Drugs:Expected Risks-Challenges in Liver Transplant
    • Prevention of hepatitis C recurrence after liver transplantation>
      • Effects of Telaprevir on Cyclosporine and Tacrolimus Pharmacokinetics Make Utility in Post-OLT Setting Uncertain
      • HCV Treatment After Liver Transplant
      • Antivirals Ineffective Against HCV After LT
  • 2013 News/Transplant
    • Liver Transplant News
  • Hepatocellular Carcinoma
    • Audio:Liver Cancer
    • Radioembolisation (RE),Selective Internal Radiation Therapy (SIRT)
    • Diagnosis (markers) of early hepatocellular carcinoma
    • Intrahepatic cholangiocarcinoma
    • Treatment TheraSphere/HCC/primary liver cancer
    • Liver Cancer : Microwave Ablation (MWA)
    • Pain May Predict Liver Cancer Prognosis
    • What Is the Indication for Sorafenib in Hepatocellular Carcinoma?
    • Liver Cysts and Tumors"Two Totally Different Concepts"
    • Interactive map of cancer mortality risk worldwide
  • 2013 News/Liver Cancer
    • Liver Cancer News and Updates
    • Vitamin E may lower liver cancer risk
  • Guidelines Nonalcoholic Fatty Liver Disease (NAFLD)
    • Fatty Liver And HCV>
      • Touching some firm ground in the epidemiology of NASH
      • Ultrasound/Liver Biopsy
      • Fatty Liver and Treatment
      • Liver fibrosis/Fatty Liver
  • 2013-Coffee and Liver Disease
  • Liver Regeneration
  • Liver Health
    • Choline: Great for the Liver
    • Medications for sleep in liver disease
    • The odds of gallbladder disease in Hepatitis C Patients
    • HCV & Gallbladder Disease:
    • Enlarged Spleen
    • HCV And Cardiovascular Risk
  • Nutrition-Herbs-Vitamins
    • Vitamin D and Treatment
    • Liver Disease - The Mediterranean Diet
    • Diet: Cirrhosis>
      • Low-Salt Diet-A Must in Cirrhosis
      • Diet for Liver Disease Low Sodium and More
      • Vitamin B12 supplements may help treat hepatitis
      • Nutrition in end-stage liver disease
      • Cirrhosis; Vitamin K Deficiencies
      • Vitamin D Levels In Cirrhosis
      • Vitamin D could de-stress Liver Disease Treatments
      • Drugs And Cirrhosis
      • Cancer and Berries
  • 2013-Silymarin for HCV infection
  • Milk Thistle
    • 2012-Milk Thistle No Help in Tough Hepatitis C Cases
    • Silymarin-Milk Thistle for NAFLD
    • Milk thistle"- Silibinin in hepatitis C related liver transplantation
    • Milk Thistle is coming to America
    • Caution! Herbs and Nutritional Supplements
  • HCV Drugs: Financial Support
  • HCV Filing For Social Security
  • Hepatitis C: A Rational Call To Arms
    • Hepatitis C; A Forced Legacy
    • Outsourcing:Globalization of the pharmaceutical industry>
      • Inspirational
  • Hepatitis C Links / Best On The Web
    • Chat and Message Boards
  • Whose Website Is This ?
  • Feedback/Contact Us

Dry Mouth (Xerostomia)

 PDF: (English / Spanish / Japanese)

Dry mouth, usually  called ‘xerostomia’ (zeer-oh-stomia), is a common symptom most often caused by a decrease in the amount of saliva or a change in the quality of saliva. The exact  number of people affected by dry mouth is unknown but it appears to be a common  condition. Estimates range from 1% to 65%, depending on the types of patient  populations studied.
 
Saliva is an essential body fluid that contributes to the protection and preservation of the oral cavity and plays a major role in maintaining oral health and comfort. It is produced by the three pairs of major salivary glands and hundreds of minor salivary glands. Its value is seldom appreciated until  there is not enough. Saliva is necessary to moisten the mouth, to lubricate
food  for easier swallowing, to protect oral hard and soft tissues, to modulate oral  microbial populations, to provide initial digestive enzymes, and to promote soft  tissue repair and oral cleansing. Cleary, the lack of adequate saliva can lead  to numerous clinical conditions affecting one’s oral and systemic health,  comfort and quality of life. As a result, detecting the early signs of dry mouth  is critical.

Role of Saliva 


x
Picture
.
Causes of Dry Mouth Dry mouth is typically caused by a multitude of factors including: medication side effects, various disease states (see Right), head & neck irradiation, dehydration, surgery, smoking, and mouth breathing.
v
v
Diseases Associated with Dry Mouth
•Sjögren’s syndrome •HIV / AIDS •Diabetes •Hypertension •Hepatitis C •Lymphoma

Diagnosing Dry Mouth
The diagnosis of dry mouth is usually made after your dentist or physician  carefully assesses your medical history and the clinical findings. Your doctor  will want to determine if your dry mouth is caused by a change in salivary  function, its severity, and its cause. In some cases, they may need to order  more specialized tests to assess your particular situation (see Table
below).

Diagnostic Considerations for Dry Mouth

  • History — Specifics of the complaint of dry mouth are obtained: duration,
      frequency, and severity. The history of dryness at other sites (eyes, nose,
      throat, skin, vagina) is documented. A complete medical and prescription drug
      history is obtained.

  • Examination — Major salivary glands are palpated for the presence of
      tenderness, firmness, or enlargement. The amount and quality of saliva coming
      from the ducts inside the mouth is assessed. The presence of dry or reddish
    oral  mucosa is noted. The extent and pattern of dental decay is evaluated.

  • Salivary flow rate — In this test, the amount of saliva produced during a
      specified amount of time may be measured. The test is non-invasive and
      painless.

  • Scintigraphy — Performed in the hospital, this test measures the rate at
      which a small amount of injected radioactive material is taken up from the
    blood  by the salivary glands and secreted into the mouth. It is another method
    to  measure salivary flow rate.

  • Biopsy of minor salivary glands — A small, shallow incision is made inside
      the lower lip to remove at least four of minor salivary glands. A pathologist
      then examines them for changes characteristic of the salivary component of
      Sjögren’s syndrome.

QUESTIONS AND ANSWERS ABOUT DRY MOUTH

Q: Which medications are associated with dry  mouth?
A: Over 1100 medications, either prescription or over the counter, have the potential to cause dry mouth (Table 
below). It has been reported that taking more than one medication with dry mouth  as a side effect increases one’s probability of experiencing dry mouth and / or  its severity. Some medications are more drying than others. Your dentist may  recommend you speak with your physician to determine if adjusting or changing  your medications could help reduce your dry mouth


Antiacne agents
Antianxiety  agents
Anticonvulsants
Antidepressants
Antidiarrheal  agents
Antidysrhythmics
Antihistamines
Antinausea  agents
Antipsychotics
Anorexiants
Antacids

Bronchodilators
Decongestants
Diuretics
High blood pressure  medications
Muscle relaxants
Narcotic analgesics
Nonsteroidal anti-inflammatory drugs
Opioid analgesics
Parkinson’s disease medications
Sedatives
Smoking-cessation agents
Urinary incontinence agents

Q: What is Sjögren’s syndrome?
A: Sjögren’s syndrome is an autoimmune condition characterized by dry mouth and dry  eyes. Other potential symptoms include debilitating fatigue and joint pain. An  estimated 1 – 4 million people are affected by the syndrome and women are
  affected nine times more frequently than. Sjögren’s syndrome can affect any age  group but most patients are diagnosed in their early 50’s. It is not unusual for  their dryness symptoms to have existed for years prior to the diagnosis.
Oral  dryness in these patients my progress up to point and then level off; or it may  progressively worsen. Further information on this important disease is  available  at the Sjögren’s Syndrome Foundation website: http://www.sjogrens.org/ .

Q: Is there a relationship between rheumatoid arthritis and dry  mouth?
A: Yes, up to 50% of individuals with  rheumatoid arthritis also suffer from dry mouth. The term secondary Sjögren’s
  syndrome is used to refer to individuals with a connective tissue disease such as rheumatoid arthritis or systemic lupus erythematosus who also experience dry eyes and dry mouth.


Q: How does radiation treatment cause   dryness?
A: Radiation therapy is often used to treat patients diagnosed with head and neck cancer. While the radiation is
  targeted to destroy only cancer cells, it invariably also destroys other healthy  cells in the site being treated. If salivary glands are within that treatment  site, they may be irreversibly damaged and no longer able to produce  saliva.  Patients suffering from radiation-induced dry mouth produce less saliva and  their remaining saliva tends to feel thick and ropey. The degree of dryness is  directly dependent on the extent of the salivary gland damage and varies from  patient to patient. Once the salivary gland has been injured, it cannot  repair  itself, so the dryness will persist.


Q: How is dry mouth treated?
A: Please  see the PATIENT  INFORMATION SHEET: Management of Dry Mouth.


The information contained in this monograph is for educational purposes only.
  This information is not a substitute for professional medical advice diagnosis,  or treatment. If you have or suspect you may have a health concern, consult your  professional health care provider. Reliance on any information  provided in this  monograph is solely at your own risk.
 
 
ABOUT THE AMERICAN ACADEMY OF ORAL MEDICINE (AAOM) – The AAOM is a 501c6,
  nonprofit organization founded in 1945 as the American Academy of Dental
  Medicine and took its current name in 1966. The members of the American Academy
  of Oral Medicine include an internationally recognized group of health care
  professionals and experts concerned with the oral health care of patients who
  have complex medical conditions, oral mucosal disorders, and / or chronic
  orofacial pain. Oral Medicine is the field of dentistry concerned with the oral
  health care of medically complex patients and with the diagnosis and
  non-surgical management of medically-related disorders or conditions affecting
  the oral and maxillofacial region.


The American Academy of Oral Medicine • (425)   778-6162 www.aaom.com • PO Box 2016 • Edmonds • WA  
98020-9516

Copyright 2010-2013 Hepatitis C New Drug Research And Liver Health